SCHEMBL17464947

SCHEMBL17464947

Cc1cc(C)c(-c2nccc(=O)n2Cc2ccc(Cl)cc2)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.48
▸ P2RX3 P56373 2/20 0.42
▸ BRD4 O60885 1/20 0.42
▸ THRB P10828 1/20 0.40
▸ APAF1 O14727 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ POLB P06746 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ UBE2N P61088 1/20 0.39
▸ RGS4 P49798 1/20 0.39
▸ RGS8 P57771 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15215745 0.78 ALDH1A1 (0.52) KDM4EP2RX3THRBALDH1A1GAA
SCHEMBL17464948 0.78 P2RX3 (0.47) KDM4EP2RX3BRD4THRBAPAF1
SCHEMBL17464946 0.78 P2RX3 (0.48) KDM4EP2RX3BRD4THRBAPAF1
SCHEMBL17879620 0.74 P2RX3 (0.49) KDM4EP2RX3BRD4ALDH1A1GAA
SCHEMBL15015882 0.71 ATM (0.47) KDM4EP2RX3ALDH1A1GAAPOLB
SCHEMBL27864221 0.66 ALDH1A1 (0.51) KDM4EBRD4ALDH1A1GAASMN1; SMN2
SCHEMBL11719377 0.64 P2RX3 (0.54) KDM4EP2RX3THRBALDH1A1POLB
SCHEMBL28070652 0.64 TP53 (0.65) APAF1ALDH1A1MAPTSMN1; SMN2
SCHEMBL11460374 0.63 MEN1 (0.60) KDM4EALDH1A1GAAPOLBMAPT
Hydrochloric Acid SCHEMBL1047768 0.62 BRD4 (0.43) BRD4SMN1; SMN2LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550763-B2 Heterocyclic ring and carbocyclic derivative SHIONOGI & CO., LTD. (JP) 2017-01-24 — — US disclosed
US-20160024072-A1 Heterocyclic Ring and Carbocyclic Derivative SHIONOGI & CO., LTD. (JP) 2016-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024072-A1 Heterocyclic Ring and Carbocyclic Derivative P2RX3, P2RX7, P2RX2 KDM4E 3118/4885P2RX3 1/4885BRD4 803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback